Janse van Rensburg, Dina Christina
(Media 24, 2013-06)
Infliximab (REVELLEX®) is a chimeric IgG1κ monoclonal antibody against tumor necrosis factor-α
(TNF-α). Infliximab is indicated, for the treatment of rheumatoid arthritis (RA), ankylosing
spondylitis (AS), psoriatic ...